ASHLEY RIOUSE: Open Payments
NPI 1194227744 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 148 payments from 28 companies in 2025. Trend: 2023 $2,419 · 2024 $2,188 · 2025 $2,675
Food & beverage: $2,628Education: $47
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $504 |
| GENZYME CORPORATION | 13 | $357 |
| CSL Behring | 10 | $191 |
| Vanda Pharmaceuticals Inc. | 23 | $185 |
| UCB, Inc. | 8 | $171 |
| ABBVIE INC. | 14 | $143 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
Products named: DUPIXENT, SAPHNELO, FANAPT, Bimzelx, Hizentra, FASENRA, NEFFY, QULIPTA.
Industry payments across OK — which companies pay providers there.
